Hepatitis C virus core protein regulates NANOG expression via the stat3 pathway

FEBS Letters

Volumn 588, Issue 4, 2014, Pages 566-573

  Zhou, Jia Jia ^a   Chen, Ru Fu ^a   Deng, Xiao Geng ^a   Zhou, Yu ^a   Ye, Xiao ^a   Yu, Min ^a   Tang, Jing ^a   He, Xiao Yu ^b   Cheng, Di ^a   Zeng, Bing ^a   Zhou, Quan Bo ^a   Li, Zhi Hua ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Guangdong Provincial Institute of Sports Science   (China)

Author keywords

Hepatitis C virus core protein; Hepatocellular carcinoma; NANOG; Stat3 pathway

Indexed keywords

CORE PROTEIN; CYCLIN D1; PHOSPHOPROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR NANOG;

ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL GROWTH; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE SILENCING; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

HEPATITIS C VIRUS CORE PROTEIN; HEPATOCELLULAR CARCINOMA; NANOG; STAT3 PATHWAY;

BASE SEQUENCE; CARCINOGENESIS; CELL CYCLE; CYCLIN D1; GENE KNOCKDOWN TECHNIQUES; HEP G2 CELLS; HEPACIVIRUS; HOMEODOMAIN PROTEINS; HUMANS; LIVER NEOPLASMS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; UP-REGULATION; VIRAL CORE PROTEINS;

EID: 84896706634     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.11.041     Document Type: Article

References (36)

1. W.H. Caselmann, and M. Alt Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma J. Hepatol. 24 1996 61 66 (Pubitemid 26267065)
2. T. Suzuki, H. Aizaki, K. Murakami, I. Shoji, and T. Wakita Molecular biology of hepatitis C virus J. Gastroenterol. 42 2007 411 423 (Pubitemid 47050003)
3. N. Kato, H. Yoshida, S.K. Ono-Nita, J. Kato, T. Goto, M. Otsuka, K. Lan, K. Matsushima, Y. Shiratori, and M. Omata Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer Hepatology 32 2000 405 412 (Pubitemid 30614674)
4. S. Shen, M. Niso-Santano, S. Adjemian, T. Takehara, S.A. Malik, H. Minoux, S. Souquere, G. Mariño, S. Lachkar, L. Senovilla, L. Galluzzi, O. Kepp, G. Pierron, M.C. Maiuri, H. Hikita, R. Kroemer, and G. Kroemer Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity Mol. Cell 48 2012 667 680
5. T. Yoshida, T. Hanada, T. Tokuhisa, K. Kosai, M. Sata, M. Kohara, and A. Yoshimura Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation J. Exp. Med. 196 2002 641 653 (Pubitemid 35024442)
6. K. Moriya, H. Fujie, Y. Shintani, H. Yotsuyanagi, T. Tsutsumi, K. Ishibashi, Y. Matsuura, S. Kimura, T. Miyamura, and K. Koike The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice Nat. Med. 4 1998 1065 1067 (Pubitemid 28417341)
7. L.A. Boyer, T.I. Lee, M.F. Cole, S.E. Johnstone, S.S. Levine, J.P. Zucker, M.G. Guenther, R.M. Kumar, H.L. Murray, R.G. Jenner, D.K. Gifford, D.A. Melton, R. Jaenisch, and R.A. Young Core transcriptional regulatory circuitry in human embryonic stem cells Cell 122 2005 947 956 (Pubitemid 41345211)
8. C.T. Freberg, J.A. Dahl, S. Timoskainen, and P. Collas Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract Mol. Biol. Cell 18 2007 1543 1553 (Pubitemid 46717539)
9. I. Ben-Porath, M.W. Thomson, V.J. Carey, R. Ge, G.W. Bell, A. Regev, and R.A. Weinberg An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors Nat. Genet. 40 2008 499 507 (Pubitemid 351601215)
10. M. Zbinden, A. Duquet, A. Lorente-Trigos, S.N. Ngwabyt, I. Borges, and A. Ruiz i Altaba NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53 EMBO J. 29 2010 2659 2674
11. G.M. Seigel, A.S. Hackam, A. Ganguly, L.M. Mandell, and F. Gonzalez-Fernandez Human embryonic and neuronal stem cell markers in retinoblastoma Mol. Vision 13 2007 823 832 (Pubitemid 46908324)
12. H.M. Meng, P. Zheng, X.Y. Wang, C. Liu, H.M. Sui, S.J. Wu, J. Zhou, Y.Q. Ding, and J.M. Li Overexpression of nanog predicts tumor progression and poor prognosis in colorectal cancer Cancer Biol. Ther. 9 2010 295 302
13. L. Ma, D. Lai, T. Liu, W. Cheng, and L. Guo Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3 Acta Biochim. Biophys. Sin. (Shanghai) 42 2010 593 602
14. K. Machida, H. Tsukamoto, H. Mkrtchyan, L. Duan, A. Dynnyk, H.M. Liu, K. Asahina, S. Govindarajan, R. Ray, J.H. Ou, E. Seki, R. Deshaies, K. Miyake, and M.M. Lai Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog Proc. Natl. Acad. Sci. USA 106 2009 1548 1553
15. J.E. Darnell Jr. STATs and gene regulation Science 277 1997 1630 1635 (Pubitemid 27446219)
16. P.A. Johnston, and J.R. Grandis STAT3 signaling: anticancer strategies and challenges Mol. Interv. 11 2011 18 26
17. R.F. Chen, Z.H. Li, R.Y. Liu, X.H. Kong, Q.B. Tang, and J. Wang Malignant transformation of the cultured human normal biliary tract epithelial cells induced by hepatitis C virus core protein Oncol. Rep. 17 2007 105 110
18. A. Reynolds, D. Leake, Q. Boese, S. Scaringe, W.S. Marshall, and A. Khvorova Rational siRNA design for RNA interference Nat. Biotechnol. 22 2004 326 330 (Pubitemid 38295766)
19. M. Kim, D. Shin, S.I. Kim, and M. Park Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model Virus Res. 122 2006 1 10 (Pubitemid 44634825)
20. L. Hyslop, M. Stojkovic, L. Armstrong, T. Walter, P. Stojkovic, S. Przyborski, M. Herbert, A. Murdoch, T. Strachan, and M. Lako Downregulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages Stem Cells 23 2005 1035 1043 (Pubitemid 41377718)
21. A. Suzuki, A. Raya, Y. Kawakami, M. Morita, T. Matsui, K. Nakashima, F.H. Gage, C. Rodríguez-Esteban, and J.C. Izpisúa Belmonte Nanog binds to Smad1 and blocks bone morphogenetic protein-induced differentiation of embryonic stem cells Proc. Natl. Acad. Sci. USA 103 2006 10294 10299 (Pubitemid 44051160)
22. Y. Sato, J. Kato, R. Takimoto, K. Takada, Y. Kawano, K. Miyanishi, M. Kobune, Y. Sato, T. Takayama, T. Matunaga, and Y. Niitsu Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB Gut 55 2006 1801 1808 (Pubitemid 44893582)
23. T. Fukutomi, Y. Zhou, S. Kawai, H. Eguchi, J.R. Wands, and J. Li Hepatitis C virus core protein stimulates hepatocyte growth: correlation with upregulation of wnt-1 expression Hepatology 41 2005 1096 1105 (Pubitemid 40593917)
24. C.R. Jeter, M. Badeaux, G. Choy, D. Chandra, L. Patrawala, C. Liu, T. Calhoun-Davis, H. Zaehres, G.Q. Daley, and D.G. Tang Functional evidence that the self-renewal gene NANOG regulates human tumor development Stem Cells 27 2009 993 1005
25. K. Mitsui, Y. Tokuzawa, H. Itoh, K. Segawa, M. Murakami, K. Takahashi, M. Maruyama, M. Maeda, and S. Yamanaka The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells Cell 113 2003 631 642 (Pubitemid 36694188)
26. S.H. Chiou, C.C. Yu, C.Y. Huang, S.C. Lin, C.J. Liu, T.H. Tsai, S.H. Chou, C.S. Chien, H.H. Ku, and J.F. Lo Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma Clin. Cancer Res. 14 2008 4085 4095
27. S. Nirasawa, D. Kobayashi, N. Tsuji, K. Kuribayashi, and N. Watanabe Diagnostic relevance of overexpressed Nanog gene in early lung cancers Oncol. Rep. 22 2009 587 591
28. T. Liu, F. Xu, X. Du, D. Lai, T. Liu, Y. Zhao, Q. Huang, L. Jiang, W. Huang, W. Cheng, and Z. Liu Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1 Mol. Cell. Biochem. 340 2010 265 273
29. J. Shan, J. Shen, L. Liu, F. Xia, C. Xu, G. Duan, Y. Xu, Q. Ma, Z. Yang, Q. Zhang, L. Ma, J. Liu, S. Xu, X. Yan, P. Bie, Y. Cui, X.W. Bian, and C. Qian Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma Hepatology 56 2012 1004 1014
30. Y.L. Lin, Z.B. Han, F.Y. Xiong, L.Y. Tian, X.J. Wu, S.W. Xue, Y.R. Zhou, J.X. Deng, and H.X. Chen Malignant transformation of 293 cells induced by ectopic expression of human Nanog Mol. Cell. Biochem. 351 2011 109 116
31. A. Arzumanyan, T. Friedman, I.O. Ng, M.M. Clayton, Z. Lian, and M.A. Feitelson Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? Cancer Res. 71 2011 3701 3708
32. L.Y. Bourguignon, K. Peyrollier, W. Xia, and E. Gilad Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells J. Biol. Chem. 283 2008 17635 17651
33. B.B. Aggarwal, A.B. Kunnumakkara, K.B. Harikumar, S.R. Gupta, S.T. Tharakan, C. Koca, S. Dey, and B. Sung Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann. NY Acad. Sci. 1171 2009 59 76
34. J. Zhang, X. Wang, B. Chen, G. Suo, Y. Zhao, Z. Duan, and J. Dai Expression of Nanog gene promotes NIH3T3 cell proliferation Biochem. Biophys. Res. Commun. 338 2005 1098 1102 (Pubitemid 41597751)
35. J. Han, F. Zhang, M. Yu, P. Zhao, W. Ji, H. Zhang, B. Wu, Y. Wang, and R. Niu RNA interference-mediated silencing of NANOG reduces cell proliferation and induces G0/G1 cell cycle arrest in breast cancer cells Cancer Lett. 321 2012 80 88
36. M. Zhao, B. Jiang, and F.H. Gao Small molecule inhibitors of STAT3 for cancer therapy Curr. Med. Chem. 18 2011 4012 4018